The study published in JAMA Health Forum found that most phase 2/phase 3 oncology clinical trials do not report data on American Indian/Alaska Native, Native Hawaiian, Black or African American, and Hispanic individuals. The representation of these groups in published clinical trials was low, with zero representation for American Indian/Alaska Native and Native Hawaiian populations. Researchers highlighted the need for improvements in including diverse populations in clinical trials to address health disparities. They also emphasized the importance of a culturally competent and diverse workforce to engage indigenous populations and improve health outcomes for marginalized communities.
Source link
American Indian, Native Hawaiian data ‘effectively nonexistent’ in cancer trials

Share This Article